Literature DB >> 2929200

Gastric banding in the treatment of morbid obesity. Factors influencing immediate and long-term results.

E J Sjøberg1, E Andersen, R Hoel, S Reinertsen, O Søreide.   

Abstract

Gastric banding for morbid obesity was performed on 73 patients between April 1983 and December 1986. Early complications occurred in 16% and late complications in 15% of the cases. A second operation was performed on 12 patients, with removal of the band in 11 (15%). Initial weight loss was rapid. Re-examination of 67 patients indicated that this initial loss was followed by a time-related weight gain. Weight reduction occurred as a fairly constant proportion of preoperative weight, irrespective of the degree of obesity. Weight loss to body mass index less than or equal to 30 seems to be a realistic expectation only for moderately overweight patients, not for the hyperobese. Older patients had least weight loss. The data suggest that dietary restrictions will still be needed after gastric banding.

Entities:  

Mesh:

Year:  1989        PMID: 2929200

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  4 in total

1.  Letter to the editor.

Authors:  Mario Morino; Gitana Scozzari
Journal:  Obes Surg       Date:  2014-01       Impact factor: 4.129

2.  The Effect of Age, Gender, and Baseline BMI on Weight Loss Outcomes in Obese Patients Undergoing Intragastric Balloon Therapy.

Authors:  Abdul-Rahman F Diab; Emad M Abdurasul; Fadi H Diab
Journal:  Obes Surg       Date:  2019-11       Impact factor: 4.129

3.  Prospective investigation of complications, reoperations, and sustained weight loss with an adjustable gastric banding device for treatment of morbid obesity.

Authors:  C Doherty; J W Maher; D S Heitshusen
Journal:  J Gastrointest Surg       Date:  1998 Jan-Feb       Impact factor: 3.452

4.  Greater short-term weight loss in women 20-45 versus 55-65 years of age following bariatric surgery.

Authors:  Christopher N Ochner; Julio Teixeira; Nori Geary; Lori Asarian
Journal:  Obes Surg       Date:  2013-10       Impact factor: 4.129

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.